Curis, Inc. (NASDAQ:CRIS) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Curis Provides Second Quarter 2024 Business Update Conference Call. At this time, all lines are in listen-only mode.
Curis Inc (CRIS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 582,273 | $4,017,684 | 0.07% | |
| 2. | M28 Capital Marc Elia | 421,951 | $2,911,462 | 3.77% | |
| 3. | Kingdon Capital Mark Kingdon | 345,730 | $2,385,537 | +22% | 0.25% |
| 4. | Point72 Asset Management Steve Cohen | 108,356 | $747,656 | +796% | 0% |
| 5. | Renaissance Technologies Jim Simons | 93,172 | $642,887 | +2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 25,000 | Director | 51,596 | 2017-11-16 | Filing | |
| $1.06 | 50,000 | Officer, Director | 115,890 | 2017-11-15 | Filing | |
| $2.40 | 10,208,333 | Large Shareholder | 27,328,464 | 2016-09-07 | Filing | |
| $1.60 | 62,890 | Officer, Director | 65,890 | 2014-08-27 | Filing | |
| $2.52 | 3,000 | Officer | 3,000 | 2013-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.07 | 3,094 | Officer, Director | 64,877 | 2022-01-31 | Filing | |
| $3.18 | 2,406 | Officer, Director | 67,971 | 2022-01-27 | Filing | |
| $10.59 | 3,094 | Officer, Director | 67,268 | 2021-01-26 | Filing | |
| $10.96 | 2,283 | Officer, Director | 70,362 | 2021-01-25 | Filing | |
| $1.64 | 3,094 | Officer, Director | 42,158 | 2020-01-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 218,600 | $2,787,150 | 0% | |
| 2. | 208,476 | $2,658,069 | 0% | |
| 3. | 197,600 | $2,519,400 | 0% | |
| 4. | 91,872 | $1,171,368 | 0% | |
| 5. | 62,682 | $799,373 | 0% |
News See All
Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
Curis, Inc. misses on earnings expectations. Reported EPS is $-2.0534 EPS, expectations were $-1.94.
Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript
Curis, Inc. misses on earnings expectations. Reported EPS is $-2.03 EPS, expectations were $-1.91. Curis, Inc.
Curis, Inc. (NASDAQ:CRIS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Curis' Third Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Curis’ Second Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis First Quarter 2023 Business Update Call. Please note, this event is being recorded.
Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis Fourth Quarter 2022 Business Update Call. Please note, this event is being recorded.
5 Stocks to Invest In Under $20 According to Michael Castor's Sio Capital
In this piece, we will take a look at the five stocks to invest in under $20 according to Sio Capital.
5 Best Biotech Stocks Under $5
Agenus Inc. (NASDAQ:AGEN) is a clinical-stage immuno-oncology company based in Lexington, Massachusetts.
Billionaire Hedge Funds
